In order to drive meaningful advancements in clinical practice and therapeutic innovation, biopharma organizations are increasingly looking to Investigator-Initiated Trials (IIT) programs. And for the Medical Affairs team who often lead these IIT programs, the task of maximizing IIT efficiency and impact is challenging - including multifaceted process management which involves strategically aligning policies, optimizing funding strategies, and refining approval processes to ensure IIT programs deliver maximum value in a timely manner.
Best Practices, LLC conducted this benchmarking research to evaluate IIT management structures, staffing, budgets, and performance metrics across large and mid-small biopharma organizations. The findings and benchmarks from this report will empower Medical Affairs teams to enhance IIT capacity in key operational regions, optimize program investments, right-size study costs to remain competitive, negotiate fees effectively, manage intellectual property, enlist MSL support strategically, improve external engagement, and ultimately strengthen the overall impact of IIT programs.